Exposure to a change in ovarian steroid levels but not continuous stable levels triggers PMDD symptoms following ovarian suppression

Por Schmidt, Peter J., Martinez, Pedro E., Nieman, Lynnette K., Koziol, Deloris E., Thompson, Karla D., Schenkel, Linda, Wakim, Paul G., Rubinow, David R.
Publicado no Am J Psychiatry (2017)

5α-Reductase Inhibition Prevents the Luteal Phase Increase in Plasma Allopregnanolone Levels and Mitigates Symptoms in Women with Premenstrual Dysphoric Disorder

Por Martinez, Pedro E, Rubinow, David R, Nieman, Lynnette K, Koziol, Deloris E, Morrow, A Leslie, Schiller, Crystal E, Cintron, Dahima, Thompson, Karla D, Khine, Khursheed K, Schmidt, Peter J
Publicado no Neuropsychopharmacology (2016)